Cooling to see if targeted or ambient cooling reduces menopausal hot flashes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares three cooling approaches during hot flashes: room temperature, ambient cooling, and targeted skin cooling. It uses a controlled setup to apply cooling when a hot flash occurs and measures physiological and symptomatic responses. Eligible participants are women ages 40–65 who are in menopause transition or postmenopause and meet language and education requirements. The study is sponsored by SRI International with collaboration from NIA and Stanford University and is conducted at SRI International in Menlo Park, CA.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Female
* Age range: 40 to 65 years and in menopausal transition or post-menopause;
* At least 8 years of education to ensure adequate reading proficiency;
* Primary language is English or Spanish.

Exclusion Criteria:

* History of medical or neurological illness or trauma that would affect the central nervous system (e.g., stroke, multiple sclerosis, epilepsy);
* Current severe medical conditions (e.g. Diabetes, cancer, cardiovascular disease, renal or hepatic disease, thyroid disorders);
* History of schizophrenia and/or bipolar disorder;
* Dependence or abuse of illicit substances in the past year;
* Current use of hormone therapy or other treatments for hot flash symptoms

Where it's running

• SRI International
  Menlo Park, California, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Dietary guidelines-based eating plan to reduce menopausal symptoms in overweight and obese women

  A randomized trial will test whether following healthy eating guidance from Brazil’s dietary guidelines can lessen menopausal symptoms in women who are overweight or obese.

  Recruiting Federal University of Health Science of Porto Alegre · Porto Alegre, Rio Grande do Sul · NCT07822230

• Haelan 951 for menopause symptoms in peri- and postmenopausal women

  This open-label study tests daily Haelan 951, a fermented soy product, to see if it helps with hot flashes, sleep, and quality of life in peri- and postmenopausal women.

  Recruiting Spectrum Clinical Research, LLC · Kansas City, Missouri · NCT07751029

• Tirzepatide for hot flashes and biological aging in postmenopausal women with obesity

  This trial will test whether tirzepatide reduces bothersome hot flashes and improves measures of biological aging in postmenopausal women with obesity.

  Recruiting Phase 4 Mayo Clinic · Jacksonville, Florida · NCT07218445

• Improving midlife women's health during the menopausal transition

  This study will test whether medicines (metformin, semaglutide, blood pressure and cholesterol drugs) combined with lifestyle changes can reduce bothersome menopausal symptoms and lower future heart and metabolic disease risk in women aged 45–55 who are in the late menopausal transition.

  Recruiting at 3 sites Phase 2/3 University of Colorado, Denver · Aurora, Colorado and 2 other locations · NCT06975111

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.